Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens

J Med Chem. 2019 May 9;62(9):4586-4605. doi: 10.1021/acs.jmedchem.9b00149. Epub 2019 Apr 19.

Abstract

Commensalism coinfection of pathogens has seriously jeopardized human health. Currently, Kunitzin-RE, as an amphibian-derived bioactivity peptide, is regarded as a potential antimicrobial candidate. However, its antimicrobial properties were unsatisfactory. In this study, a set of shortened variants of Kunitzin-RE was developed by the interception of a peptide fragment and single-site mutation to investigate the effect of chain length, positive charge, hydrophobicity, amphipathicity, and secondary structure on antimicrobial properties. Among them, W8 (AARIILRWRFR) significantly broadened the antimicrobial spectrum and showed the highest antimicrobial activity (GMall = 2.48 μM) against all the fungi and bacteria tested. Additionally, W8 showed high cell selectivity and salt tolerance in vitro, whereas it showed high effectiveness against mice keratitis cause by infection by C. albicans 2.2086. Additionally, it also had obviously lipopolysaccharide-binding ability and a potent membrane-disruptive mechanism. Overall, these findings contributed to the design of short antimicrobial peptides and to combat the serious threat of commensalism coinfection of pathogens.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Anti-Bacterial Agents / toxicity
  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use*
  • Antifungal Agents / toxicity
  • Antimicrobial Cationic Peptides / pharmacology
  • Antimicrobial Cationic Peptides / therapeutic use*
  • Antimicrobial Cationic Peptides / toxicity
  • Candida albicans / drug effects
  • Cell Membrane / drug effects
  • Cell Membrane Permeability / drug effects
  • Coinfection / drug therapy
  • Drug Design
  • Escherichia coli / drug effects
  • Eye Infections, Fungal / drug therapy
  • Keratitis / drug therapy
  • Mice
  • Microbial Sensitivity Tests
  • Protein Conformation, alpha-Helical
  • Protein Engineering
  • RAW 264.7 Cells
  • Salmonella typhimurium / drug effects
  • Staphylococcus aureus / drug effects

Substances

  • Anti-Bacterial Agents
  • Antifungal Agents
  • Antimicrobial Cationic Peptides